Clement Penny to Cell Line, Tumor
This is a "connection" page, showing publications Clement Penny has written about Cell Line, Tumor.
Connection Strength
0,544
-
Epigenetic regulation in colorectal cancer: The susceptibility of microRNAs 145, 143 and 133b to DNA demethylation and histone deacetylase inhibitors. PLoS One. 2023; 18(8):e0289800.
Score: 0,220
-
Aberrant Apoptotic Response of Colorectal Cancer Cells to Novel Nucleoside Analogues. PLoS One. 2015; 10(9):e0138607.
Score: 0,128
-
A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer. Br J Pharmacol. 2024 01; 181(1):107-124.
Score: 0,055
-
Targeting AXL in mesothelioma: From functional characterization to clinical implication. Crit Rev Oncol Hematol. 2023 Aug; 188:104043.
Score: 0,054
-
Mitotic syndicates Aurora Kinase B (AURKB) and mitotic arrest deficient 2 like 2 (MAD2L2) in cohorts of DNA damage response (DDR) and tumorigenesis. Mutat Res Rev Mutat Res. 2021 Jan-Jun; 787:108376.
Score: 0,047
-
Chemotherapeutic Efficacy of Implantable Antineoplastic-Treatment Protocols in an Optimal Mouse Model for Human Ovarian Carcinoma Cell Targeting. Int J Mol Sci. 2018 Oct 04; 19(10).
Score: 0,039